Log In
Print
BCIQ
Print
Print this Print this
 

melflufen (formerly J1)

  Manage Alerts
Collapse Summary General Information
Company Oncopeptides AB
DescriptionProdrug of melphalan
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationMultiple myeloma (MM)
Indication DetailsTreat relapsed and/or relapsed-refractory multiple myeloma (MM)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today